User: Guest

INDUCED PLURIPOTENT STEM CELL (IPSC)

Global Market Trajectory & Analytics

MCP12568

VALIDATED EXECUTIVE ENGAGEMENTS

POOL + OUTREACH

1737
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

313
Interactions with Platform & by Email

PARTICIPANTS

69
Unique # Participated

VALIDATIONS

31
Responses Validated*
* Login to view program details and full enterprise executive list.

DATE

SEPTEMBER 2020

TABLES

108

PAGES

397

EDITION

9

PRICE

USD $4950


The global market for Induced Pluripotent Stem Cell ((iPSC) is projected to reach US$1.8 billion by 2025, driven by the growing value of stem cells in medicine.

Stem cells are undifferentiated cells that hold the capability to divide, and differentiate into specialized cells in the body. Stem cells act as repair system and replenish adult tissues, maintaining the turnover of regenerative organs such as the blood and skin. In organs, such as the bone marrow, stem cells frequently form replacement cells to repair the worn out tissue. These cells can respond to signals from the body and transverse a particular developmental pathway to differentiate into one specific cell type. Due to their regenerative properties, stem cells are being researched for therapeutic applications in diabetes, cardiovascular disease, neurodegenerative disease, cancer, autoimmune diseases, spinal cord defects, among others. Stem Cell research is an exciting field where continuous discoveries are being made on new sources of stem cells and new methods of their acquisition and harvesting. Of late, adult stem cells have garnered a lion`s share of the stem cell space, purely based on the fact that they require less expensive clinical trials, need to comply with fewer regulatory norms and ethical issues compared to other stem cell variants such as embryonic stem cells. Researchers around the world have been focusing research activities to develop adult stem cell therapies in order to combat a variety of diseases ranging from diabetes to heart disease. Factually, adult stem cells are the only stem cells that have been approved for use in transplants for the treatment of diseases such as cancer. Interestingly, with drug development based on embryonic stem cells being challenged amid growing debate over ethics and regulation of this research, iPSCs offers an alternate step forward in the commercialization of stem cell therapies and regenerative medicine. Embryonic stem cell research continues to remain embroiled in ethical, religious, and political controversies across various countries around the world. Induced Pluripotent Stem Cells (iPSs), which are reprogrammed to mimic embryonic stem cell-like state allowing expression of genes and human cells needed for therapeutic purposes, offers an attractive alternate way forwarding in furthering the goals of stem cell research. Pioneered in 2006 and developed in the following year, these cells are created by conversion of somatic cells into PSCs by introducing certain genes including Myc, Klf4, Oct3/4 and Sox2.

Pluripotent stem cells hold tremendous potential in the regenerative medicine arena. Based on their ability to proliferate indefinitely and develop into desirable cell type such as heart, liver, neuronal and pancreatic cells, iPSCs offer a source of new cells that can replace lost or damaged cells. For instance, iPSCs can be developed into beta islet cells, blood cells or neuronal cells for the treatment of diabetes, leukemia and neurological disorders, respectively. Parkinson`s, Alzheimer`s & spinal cord injuries are key neurologic diseases expected to benefit from iPS research. Dramatic rise in cancer cases worldwide and the need for novel anti-cancer therapies will emerge as a key driver for the growth of iPSCs. Interest in cancer research soars high on new hopes of direct reprogramming of cancer cells with enforced expression of pluripotency factors and the resulting dedifferentiation of transformed cancer cells.
Axol Bioscience Ltd.; Cynata Therapeutics Limited; Evotec SE; Fate Therapeutics, Inc.; FUJIFILM Cellular Dynamics, Inc.; Ncardia; Pluricell Biotech; REPROCELL USA, Inc.; Shenzhen Sanqi Biotechnology Co., Ltd.; Sumitomo Dainippon Pharma Co., Ltd.; Takara Bio, Inc.; Thermo Fisher Scientific, Inc.; ViaCyte, Inc.
» Cell Type (Vascular Cells, Cardiac Cells, Neuronal Cells, Liver Cells, Immune Cells, Other Cell Types) » Research Method (Cellular Reprogramming, Cell Culture, Cell Differentiation, Cell Analysis, Cellular Engineering, Other Research Methods) » Application (Drug Development & Toxicology Testing, Academic Research, Regenerative Medicine, Other Applications)
» World » USA » Canada » Japan » China » Europe » France » Germany » Italy » UK » Rest of Europe » Asia-Pacific » Rest of World

INSIDER ACCESS PRIVILEGES

Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.

ACTIVE CLIENT

INACTIVE CLIENT

ACTIVE PANELIST

INACTIVE PANELIST

OPT-INS

FEATURED COMPANIES

Registration is required to access our data stacks.

WORLD BRANDS

Registration is required to access our data stacks.

EXECUTIVES ENGAGED

Registration is required to access our data stacks.

KEY DIFFERENTIATORS

We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.

* A review of 262 off-the-shelf market report publishers worldwide.

WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.

Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.

Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)

A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.

Where relevent and possible we present competitive brands.

Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.

Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.

Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.

We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.

  
05
1. MARKET OVERVIEW
Stem Cells, Application Areas, and the Different Types: A Prelude
Applications of Stem Cells
Types of Stem Cells
Induced Pluripotent Stem Cell (iPSC): An Introduction
Production of iPSCs
First & Second Generation Mouse iPSCs
Human iPSCs
Key Properties of iPSCs
Transcription Factors Involved in Generation of iPSCs
Noteworthy Research & Application Areas for iPSCs
Induced Pluripotent Stem Cell ((iPSC) Market: Growth Prospects and Outlook
Drug Development Application to Witness Considerable Growth
Technical Breakthroughs, Advances & Clinical Trials to Spur Growth of iPSC Market
North America Dominates Global iPSC Market
Competition
Recent Market Activity
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
Axol Bioscience Ltd. (UK)
Cynata Therapeutics Limited (Australia)
Evotec SE (Germany)
Fate Therapeutics, Inc. (USA)
FUJIFILM Cellular Dynamics, Inc. (USA)
Ncardia (Belgium)
Pluricell Biotech (Brazil)
REPROCELL USA, Inc. (USA)
Shenzhen Sanqi Biotechnology Co., Ltd. (China)
Sumitomo Dainippon Pharma Co., Ltd. (Japan)
Takara Bio, Inc. (Japan)
Thermo Fisher Scientific, Inc. (USA)
ViaCyte, Inc. (USA)
3. MARKET TRENDS & DRIVERS
Induced Pluripotent Stem Cells: A Giant Leap in the Therapeutic Applications
Research Trends in Induced Pluripotent Stem Cell Space
EXHIBIT: Worldwide Publication of hESC and hiPSC Research Papers for the Period 2008-2010, 2011-2013 and 2014-2016
EXHIBIT: Number of Original Research Papers on hESC and iPSC Published Worldwide (2014-2016)
Concerns Related to Embryonic Stem Cells Shift the Focus onto iPSCs
Regenerative Medicine: A Promising Application of iPSCs
Induced Pluripotent: A Potential Competitor to hESCs?
EXHIBIT: Global Regenerative Medicine Market Size in US$ Billion for 2019, 2021, 2023 and 2025
EXHIBIT: Global Stem Cell & Regenerative Medicine Market by Product (in %) for the Year 2019
EXHIBIT: Global Regenerative Medicines Market by Category: Breakdown (in %) for Biomaterials, Stem Cell Therapies and Tissue Engineering for 2019
Pluripotent Stem Cells Hold Significance for Cardiovascular Regenerative Medicine
EXHIBIT: Leading Causes of Mortality Worldwide: Number of Deaths in Millions & % Share of Deaths by Cause for 2017
EXHIBIT: Leading Causes of Mortality for Low-Income and High-Income Countries
Growing Importance of iPSCs in Personalized Drug Discovery
Persistent Advancements in Genetics Space and Subsequent Growth in Precision Medicine Augur Well for iPSCs Market
EXHIBIT: Global Precision Medicine Market (In US$ Billion) for the Years 2018, 2021 & 2024
Increasing Prevalence of Chronic Disorders Supports Growth of iPSCs Market
EXHIBIT: Worldwide Cancer Incidence: Number of New Cancer Cases Diagnosed for 2012, 2018 & 2040
EXHIBIT: Number of New Cancer Cases Reported (in Thousands) by Cancer Type: 2018
EXHIBIT: Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
EXHIBIT: Rising Diabetes Prevalence Presents Opportunity for iPSCs Market: Number of Adults (20-79) with Diabetes (in Millions) by Region for 2017 and 2045
Aging Demographics Add to the Global Burden of Chronic Diseases, Presenting Opportunities for iPSCs Market
EXHIBIT: Expanding Elderly Population Worldwide: Breakdown of Number of People Aged 65+ Years in Million by Geographic Region for the Years 2019 and 2030
Growth in Number of Genomics Projects Propels Market Growth
EXHIBIT: Genomic Initiatives in Select Countries
EXHIBIT: New Gene-Editing Tools Spur Interest and Investments in Genetics, Driving Lucrative Growth Opportunities for iPSCs: Total VC Funding (In US$ Million) in Genetics for the Years 2014, 2015, 2016, 2017 and 2018
Launch of Numerous iPSCs-Related Clinical Trials Set to Benefit Market Growth
EXHIBIT: Number of Induced Pluripotent Stem Cells based Studies by Condition
EXHIBIT: Clinical Trials with Cells Derived from Human-Induced Pluripotent Stem Cells
iPSCs-based Clinical Trial for Heart Diseases
Induced Pluripotent Stem Cells for Stroke Treatment
Off-the-shelf Stem Cell Treatment for Cancer Enters Clinical Trial
iPSCs for Hematological Disorders
Market Benefits from Growing Funding for iPSCs-Related R&D Initiatives
EXHIBIT: Stem Cell Research Funding in the US (in US$ Million) for the Years 2011 through 2017
Human iPSC Banks: A Review of Emerging Opportunities and Drawbacks
EXHIBIT: Human iPSC Banks Worldwide: An Overview
EXHIBIT: Cell Sources and Reprogramming Methods Used by Select iPSC Banks
Innovations, Research Studies & Advancements in iPSCs
Key iPSC Research Breakthroughs for Regenerative Medicine
Researchers Develop Novel Oncogene-Free and Virus-Free iPSC Production Method
Scientists Study Concerns of Genetic Mutations in iPSCs
iPSCs Hold Tremendous Potential in Transforming Research Efforts
Researchers Highlight Potential Use of iPSCs for Developing Novel Cancer Vaccines
Scientists Use Machine Learning to Improve Reliability of iPSC Self-Organization
STEMCELL Technologies Unveils mTeSR Plus
Challenges and Risks Related to Pluripotent Stem Cells
A Glance at Issues Related to Reprogramming of Adult Cells to iPSCs
A Note on Legal, Social and Ethical Considerations with iPSCs
4. GLOBAL MARKET PERSPECTIVE
Induced Pluripotent Stem Cell (iPSC) Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025
Induced Pluripotent Stem Cell (iPSC) Market Share Shift across Key Geographies Worldwide: 2019 VS 2025
Vascular Cells (Cell Type) World Market by Region/Country in US$ Thousand: 2018 to 2025
Vascular Cells (Cell Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2019 VS 2025
Cardiac Cells (Cell Type) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025
Cardiac Cells (Cell Type) Market Sales Breakdown by Region/Country in Percentage: 2019 VS 2025
Neuronal Cells (Cell Type) Geographic Market Spread Worldwide in US$ Thousand: 2018 to 2025
Neuronal Cells (Cell Type) Market Share Distribution in Percentage by Region/Country: 2019 VS 2025
Liver Cells (Cell Type) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2018 to 2025
Liver Cells (Cell Type) Market Share Breakdown by Region/Country: 2019 VS 2025
Immune Cells (Cell Type) World Market by Region/Country in US$ Thousand: 2018 to 2025
Immune Cells (Cell Type) Market Share Distribution in Percentage by Region/Country: 2019 VS 2025
Other Cell Types (Cell Type) World Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018 to 2025
Other Cell Types (Cell Type) Market Percentage Share Distribution by Region/Country: 2019 VS 2025
Cellular Reprogramming (Research Method) Market Opportunity Analysis Worldwide in US$ Thousand by Region/Country: 2018 to 2025
Cellular Reprogramming (Research Method) Market Share Distribution in Percentage by Region/Country: 2019 VS 2025
Cell Culture (Research Method) World Market by Region/Country in US$ Thousand: 2018 to 2025
Cell Culture (Research Method) Market Share Breakdown of Worldwide Sales by Region/Country: 2019 VS 2025
Cell Differentiation (Research Method) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025
Cell Differentiation (Research Method) Market Sales Breakdown by Region/Country in Percentage: 2019 VS 2025
Cell Analysis (Research Method) Geographic Market Spread Worldwide in US$ Thousand: 2018 to 2025
Cell Analysis (Research Method) Market Share Distribution in Percentage by Region/Country: 2019 VS 2025
Cellular Engineering (Research Method) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2018 to 2025
Cellular Engineering (Research Method) Market Share Breakdown by Region/Country: 2019 VS 2025
Other Research Methods (Research Method) World Market by Region/Country in US$ Thousand: 2018 to 2025
Other Research Methods (Research Method) Market Share Distribution in Percentage by Region/Country: 2019 VS 2025
Drug Development & Toxicology Testing (Application) Global Opportunity Assessment in US$ Thousand by Region/Country: 2018-2025
Drug Development & Toxicology Testing (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2019 VS 2025
Academic Research (Application) Worldwide Sales in US$ Thousand by Region/Country: 2018-2025
Academic Research (Application) Market Share Shift across Key Geographies: 2019 VS 2025
Regenerative Medicine (Application) Global Market Estimates & Forecasts in US$ Thousand by Region/Country: 2018-2025
Regenerative Medicine (Application) Market Share Breakdown by Region/Country: 2019 VS 2025
Other Applications (Application) Demand Potential Worldwide in US$ Thousand by Region/Country: 2018-2025
Other Applications (Application) Share Breakdown Review by Region/Country: 2019 VS 2025
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
United States Induced Pluripotent Stem Cell (iPSC) Market Estimates and Projections in US$ Thousand by Cell Type: 2018 to 2025
United States Induced Pluripotent Stem Cell (iPSC) Market Share Breakdown by Cell Type: 2019 VS 2025
United States Induced Pluripotent Stem Cell (iPSC) Market Estimates and Projections in US$ Thousand by Research Method: 2018 to 2025
United States Induced Pluripotent Stem Cell (iPSC) Market Share Breakdown by Research Method: 2019 VS 2025
United States Induced Pluripotent Stem Cell (iPSC) Latent Demand Forecasts in US$ Thousand by Application: 2018 to 2025
Induced Pluripotent Stem Cell (iPSC) Market Share Breakdown in the United States by Application: 2019 VS 2025
CANADA
Canadian Induced Pluripotent Stem Cell (iPSC) Market Estimates and Forecasts in US$ Thousand by Cell Type: 2018 to 2025
Induced Pluripotent Stem Cell (iPSC) Market in Canada: Percentage Share Breakdown of Sales by Cell Type for 2019 and 2025
Canadian Induced Pluripotent Stem Cell (iPSC) Market Estimates and Forecasts in US$ Thousand by Research Method: 2018 to 2025
Induced Pluripotent Stem Cell (iPSC) Market in Canada: Percentage Share Breakdown of Sales by Research Method for 2019 and 2025
Canadian Induced Pluripotent Stem Cell (iPSC) Market Quantitative Demand Analysis in US$ Thousand by Application: 2018 to 2025
Canadian Induced Pluripotent Stem Cell (iPSC) Market Share Analysis by Application: 2019 VS 2025
JAPAN
Japanese Market for Induced Pluripotent Stem Cell (iPSC): Annual Sales Estimates and Projections in US$ Thousand by Cell Type for the Period 2018-2025
Japanese Induced Pluripotent Stem Cell (iPSC) Market Share Analysis by Cell Type: 2019 VS 2025
Japanese Market for Induced Pluripotent Stem Cell (iPSC): Annual Sales Estimates and Projections in US$ Thousand by Research Method for the Period 2018-2025
Japanese Induced Pluripotent Stem Cell (iPSC) Market Share Analysis by Research Method: 2019 VS 2025
Japanese Demand Estimates and Forecasts for Induced Pluripotent Stem Cell (iPSC) in US$ Thousand by Application: 2018 to 2025
Induced Pluripotent Stem Cell (iPSC) Market Share Shift in Japan by Application: 2019 VS 2025
CHINA
Chinese Induced Pluripotent Stem Cell (iPSC) Market Growth Prospects in US$ Thousand by Cell Type for the Period 2018-2025
Chinese Induced Pluripotent Stem Cell (iPSC) Market by Cell Type: Percentage Breakdown of Sales for 2019 and 2025
Chinese Induced Pluripotent Stem Cell (iPSC) Market Growth Prospects in US$ Thousand by Research Method for the Period 2018-2025
Chinese Induced Pluripotent Stem Cell (iPSC) Market by Research Method: Percentage Breakdown of Sales for 2019 and 2025
Chinese Demand for Induced Pluripotent Stem Cell (iPSC) in US$ Thousand by Application: 2018 to 2025
Chinese Induced Pluripotent Stem Cell (iPSC) Market Share Breakdown by Application: 2019 VS 2025
EUROPE
European Induced Pluripotent Stem Cell (iPSC) Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025
European Induced Pluripotent Stem Cell (iPSC) Market Share Shift by Region/Country: 2019 VS 2025
European Induced Pluripotent Stem Cell (iPSC) Market Estimates and Forecasts in US$ Thousand by Cell Type: 2018-2025
European Induced Pluripotent Stem Cell (iPSC) Market Share Breakdown by Cell Type: 2019 VS 2025
European Induced Pluripotent Stem Cell (iPSC) Market Estimates and Forecasts in US$ Thousand by Research Method: 2018-2025
European Induced Pluripotent Stem Cell (iPSC) Market Share Breakdown by Research Method: 2019 VS 2025
European Induced Pluripotent Stem Cell (iPSC) Addressable Market Opportunity in US$ Thousand by Application: 2018-2025
European Induced Pluripotent Stem Cell (iPSC) Market Share Analysis by Application: 2019 VS 2025
FRANCE
Induced Pluripotent Stem Cell (iPSC) Market in France by Cell Type: Estimates and Projections in US$ Thousand for the Period 2018-2025
French Induced Pluripotent Stem Cell (iPSC) Market Share Analysis by Cell Type: 2019 VS 2025
Induced Pluripotent Stem Cell (iPSC) Market in France by Research Method: Estimates and Projections in US$ Thousand for the Period 2018-2025
French Induced Pluripotent Stem Cell (iPSC) Market Share Analysis by Research Method: 2019 VS 2025
Induced Pluripotent Stem Cell (iPSC) Quantitative Demand Analysis in France in US$ Thousand by Application: 2018-2025
French Induced Pluripotent Stem Cell (iPSC) Market Share Analysis: A 7-Year Perspective by Application for 2019 and 2025
GERMANY
Induced Pluripotent Stem Cell (iPSC) Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Cell Type for the Period 2018-2025
German Induced Pluripotent Stem Cell (iPSC) Market Share Breakdown by Cell Type: 2019 VS 2025
Induced Pluripotent Stem Cell (iPSC) Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Research Method for the Period 2018-2025
German Induced Pluripotent Stem Cell (iPSC) Market Share Breakdown by Research Method: 2019 VS 2025
Induced Pluripotent Stem Cell (iPSC) Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by Application for the Period 2018-2025
Induced Pluripotent Stem Cell (iPSC) Market Share Distribution in Germany by Application: 2019 VS 2025
ITALY
Italian Induced Pluripotent Stem Cell (iPSC) Market Growth Prospects in US$ Thousand by Cell Type for the Period 2018-2025
Italian Induced Pluripotent Stem Cell (iPSC) Market by Cell Type: Percentage Breakdown of Sales for 2019 and 2025
Italian Induced Pluripotent Stem Cell (iPSC) Market Growth Prospects in US$ Thousand by Research Method for the Period 2018-2025
Italian Induced Pluripotent Stem Cell (iPSC) Market by Research Method: Percentage Breakdown of Sales for 2019 and 2025
Italian Demand for Induced Pluripotent Stem Cell (iPSC) in US$ Thousand by Application: 2018 to 2025
Italian Induced Pluripotent Stem Cell (iPSC) Market Share Breakdown by Application: 2019 VS 2025
UNITED KINGDOM
United Kingdom Market for Induced Pluripotent Stem Cell (iPSC): Annual Sales Estimates and Projections in US$ Thousand by Cell Type for the Period 2018-2025
United Kingdom Induced Pluripotent Stem Cell (iPSC) Market Share Analysis by Cell Type: 2019 VS 2025
United Kingdom Market for Induced Pluripotent Stem Cell (iPSC): Annual Sales Estimates and Projections in US$ Thousand by Research Method for the Period 2018-2025
United Kingdom Induced Pluripotent Stem Cell (iPSC) Market Share Analysis by Research Method: 2019 VS 2025
United Kingdom Demand Estimates and Forecasts for Induced Pluripotent Stem Cell (iPSC) in US$ Thousand by Application: 2018 to 2025
Induced Pluripotent Stem Cell (iPSC) Market Share Shift in the United Kingdom by Application: 2019 VS 2025
REST OF EUROPE
Rest of Europe Induced Pluripotent Stem Cell (iPSC) Market Estimates and Forecasts in US$ Thousand by Cell Type: 2018-2025
Rest of Europe Induced Pluripotent Stem Cell (iPSC) Market Share Breakdown by Cell Type: 2019 VS 2025
Rest of Europe Induced Pluripotent Stem Cell (iPSC) Market Estimates and Forecasts in US$ Thousand by Research Method: 2018-2025
Rest of Europe Induced Pluripotent Stem Cell (iPSC) Market Share Breakdown by Research Method: 2019 VS 2025
Rest of Europe Induced Pluripotent Stem Cell (iPSC) Addressable Market Opportunity in US$ Thousand by Application: 2018-2025
Rest of Europe Induced Pluripotent Stem Cell (iPSC) Market Share Analysis by Application: 2019 VS 2025
ASIA-PACIFIC
Induced Pluripotent Stem Cell (iPSC) Market in Asia-Pacific by Cell Type: Estimates and Projections in US$ Thousand for the Period 2018-2025
Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market Share Analysis by Cell Type: 2019 VS 2025
Induced Pluripotent Stem Cell (iPSC) Market in Asia-Pacific by Research Method: Estimates and Projections in US$ Thousand for the Period 2018-2025
Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market Share Analysis by Research Method: 2019 VS 2025
Induced Pluripotent Stem Cell (iPSC) Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by Application: 2018-2025
Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market Share Analysis: A 7-Year Perspective by Application for 2019 and 2025
REST OF WORLD
Rest of World Induced Pluripotent Stem Cell (iPSC) Market Estimates and Forecasts in US$ Thousand by Cell Type: 2018 to 2025
Induced Pluripotent Stem Cell (iPSC) Market in Rest of World: Percentage Share Breakdown of Sales by Cell Type for 2019 and 2025
Rest of World Induced Pluripotent Stem Cell (iPSC) Market Estimates and Forecasts in US$ Thousand by Research Method: 2018 to 2025
Induced Pluripotent Stem Cell (iPSC) Market in Rest of World: Percentage Share Breakdown of Sales by Research Method for 2019 and 2025
Rest of World Induced Pluripotent Stem Cell (iPSC) Market Quantitative Demand Analysis in US$ Thousand by Application: 2018 to 2025
Rest of World Induced Pluripotent Stem Cell (iPSC) Market Share Analysis by Application: 2019 VS 2025
Total Companies Profiled : 46 (including Divisions/Subsidiaries - 46)

Click here to request a full table of contents and more details on this project.

INSIDER ACCESS TO

 METHODOLOGY  QUESTIONNAIRE  INFLUENCER NETWORK

Registration is required to access our data stacks.

RESEARCH PANEL

Panelists are carefully chosen based on their domain expertise and market influence.

Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.

Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.

  • Complimentary previews of full stack research data for participated
  • Insider access to research programs including engagements and stats from other panelists
  • Unlimited research credits of $1000 per participated project
  • Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
  • Interact with other panelists via our MarketGlassTM Data Exchange Platform*
  • BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*

* Complete details will be shared with panelists upon formal acceptance.

 GLOBAL EXPERT PANEL

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com

General queries: Info411@StrategyR.com